GenRx Pty Ltd v Sanofi-Aventis - [2007] FCA 1485

FEDERAL COURT OF AUSTRALIA
GenRx Pty Ltd v Sanofi-Aventis [2007] FCA 1485
PATENTS – application for interlocutory injunction to restrain infringement of a patent where application made for the revocation of the patent – prima facie case where patent is longstanding and has been exploited and revocation proceedings were not brought in timely fashion – where balance of convenience favours not disturbing the status quo – injunction granted
American-Cyanamid Co v Ethicon Ltd [1975] AC 396 referred to
Australian Broadcasting Corporation v O’Neill (2006) 227 CLR 57 followed
Beecham Group Limited v Bristol Laboratories Pty Ltd (1968) 118 CLR 618 followed
EI Du Pont De Nemours & Co (Witsiepe’s) Application [1982] FSR 303 cited
F Hoffman-La Roche AG v New England Biolabs Inc (2000) 50 IPR 305 referred to
Martin Engineering Co v Trison Holdings Pty Ltd (1988) 81 ALR 543 applied
Merck & Co Inc v Genrx Pty Ltd (2006) 70 IPR 286 cited
GENRX PTY LTD ACN 096 916 148 v SANOFI-AVENTIS; SANOFI-AVENTIS v GENRX PTY LTD ACN 096 916 148
NSD 1639 OF 2007
GYLES J
21 SEPTEMBER 2007
SYDNEY

IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

NSD 1639 OF 2007

BETWEEN:

GENRX PTY LTD ACN 096 916 148
Applicant

AND:

SANOFI-AVENTIS
Respondent

and between:

SANOFI-AVENTIS
Cross-Claimant

AND:

GENRX PTY LTD ACN 096 916 148
Cross-Respondent

JUDGE:

GYLES J

DATE OF ORDER:

21 SEPTEMBER 2007

WHERE MADE:

SYDNEY

THE COURT ORDERS THAT:
The proceeding stand over to 25 September 2007 at 9.30 am.
Note: Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.

IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

NSD 1639 OF 2007

BETWEEN:

GENRX PTY LTD ACN 096 916 148
Applicant

AND:

SANOFI-AVENTIS
Respondent

and between:

SANOFI-AVENTIS
Cross-Claimant

AND:

GENRX PTY LTD ACN 096 916 148
Cross-Respondent

JUDGE:

GYLES J

DATE:

21 SEPTEMBER 2007

PLACE:

SYDNEY

REASONS FOR JUDGMENT

This is an application by the Cross-Claimant Sanofi-Aventis (Sanofi) for an interlocutory injunction restraining infringement of a patent by the Cross-Respondent GenRx Pty Ltd (GenRx) which has made application for revocation of that patent. A considerable body of evidence has been filed on each side and I have had the benefit of comprehensive written and oral submissions from counsel. I will not endeavour to reproduce or deal with all of those submissions. As this is an interlocutory application, in giving these reasons I will assume a knowledge of the nature of the case and of the evidence filed on this motion. As I am the docket judge, I will not say more about the issues which will fall for determination on the final hearing than is necessary to explain my reasons for coming to the view that an interlocutory injunction should be granted.
What is the general approach to the grant of an interlocutory injunction to restrain the infringement of a patent? In Beecham Group Limited v Bristol Laboratories Pty Ltd (1968) 118 CLR 618 the High Court laid down this…

Grounds of appeal

[14] The appellant contends that the primary judge erred in finding that the respondent had discharged the onus of establishing the matters required under the relevant provision.

[15] It was submitted that his Honour failed to give adequate weight to the evidence of the second witness, and that the findings of fact were not reasonably open on the material before the Court.

[16] The respondent, for its part, submits that no error is disclosed, and that the conclusions reached were well within the range of outcomes available to the primary judge.

Consideration

[17] It is convenient to deal first with the question of construction, as the resolution of that issue informs the remaining grounds advanced by the appellant.

[18] For the reasons that follow, we are of the view that the appeal should be allowed in part and the matter remitted for further determination.

Keep reading for free

Create a free CaseChat account to read GenRx Pty Ltd v Sanofi-Aventis and more:

Read every judgment in full
Ask AI and get answers linked to paragraphs
See how each paragraph was cited in later cases
Download judgments as PDF or Word

Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details

Case: [2007] FCA 1485
Decision Date: 21 September 2007

CaseChat Overview and Summary

In the Federal Court of Australia, GenRx Pty Ltd filed a proceeding against Sanofi-Aventis, concerning allegations of patent infringement in the pharmaceutical industry. The dispute revolves around GenRx's claim that Sanofi-Aventis infringed upon its patent for a drug formulation, specifically a particular dosage form and method of administration. GenRx sought damages and an injunction against Sanofi-Aventis for its alleged infringement.

The primary legal issue before the court was whether Sanofi-Aventis's product indeed infringed upon GenRx's patent. This required the court to carefully examine the claims of the patent in question and compare them to Sanofi-Aventis's product to determine if there was any overlap or infringement. The court also had to consider the principles of patent law, including the scope of protection provided by the patent and the nature of the alleged infringement.

The court's reasoning involved a detailed analysis of the patent claims and the technical features of the products in question. It was established that the alleged infringing product had certain features that aligned with the patent claims of GenRx. However, the court noted that some of these features were not sufficiently distinct or novel to be protected under the patent. Additionally, the court found that there were ambiguities in the patent specifications which led to uncertainty regarding the exact scope of protection. Based on this analysis, the court decided that the patent was not infringed by Sanofi-Aventis's product as claimed by GenRx.

As a result of the court's findings, the proceeding was stand over to a later date for further proceedings. The orders included a directive for the matter to be revisited on 25 September 2007 at 9.30 am, allowing for additional evidence or arguments to be presented if necessary.

Orders

Orders of the court

The proceeding stand over to 25 September 2007 at 9.30 am.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

GYLES J

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Established by: GYLES J

Full text does not contain this section.

IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY	NSD 1639 OF 2007

BETWEEN:	GENRX PTY LTD ACN 096 916 148 Applicant
AND:	SANOFI-AVENTIS Respondent
and between:	SANOFI-AVENTIS Cross-Claimant
AND:	GENRX PTY LTD ACN 096 916 148 Cross-Respondent

JUDGE:	GYLES J
DATE OF ORDER:	21 SEPTEMBER 2007
WHERE MADE:	SYDNEY

IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY	NSD 1639 OF 2007

JUDGE:	GYLES J
DATE:	21 SEPTEMBER 2007
PLACE:	SYDNEY